Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)
Close on Nov 18, 2026Market cap $94.80MP/E –Yield –
Stereotaxis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Stereotaxis's pe ratio was 847.5× on Apr 30, 2019.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Apr 30, 2019 | 847.5× | +772.4 |
| 2018 | Jan 31, 2018 | 75.1× | −4.9 |
| 2017 | Dec 29, 2017 | 80.0× | – |
See a number that looks wrong?